What is Dr. Zubair Khalid's research focus?

Dr. Zubair Khalid specializes in molecular virology, mRNA vaccine development, and computational biology, with a focus on avian pathogens like IBDV and Avian Reovirus.

Where is Dr. Zubair Khalid currently working?

Dr. Zubair Khalid is a Postdoctoral Research Associate at the University of Maryland (UMD), specifically within the Department of Animal and Avian Sciences.

Avian Influenza A Virus in Poultry: Clinical Signs and Surveillance

Introduction

Avian influenza A virus (AIV) is an enveloped, negative-sense, single-stranded RNA virus belonging to the family Orthomyxoviridae [1]. The virus infects a wide range of avian species, with domestic poultry representing a primary host for both low pathogenicity (LPAI) and highly pathogenic (HPAI) strains [1, 2]. Infection outcomes vary from subclinical carriage to systemic disease with high mortality, depending on viral subtype and host factors [1]. Understanding the clinical signs and implementing robust surveillance programs are critical for early detection, control, and eradication of notifiable avian influenza [3].

Etiology

AIV is classified by the antigenicity of its surface glycoproteins: hemagglutinin (HA, 16 subtypes H1-H16) and neuraminidase (NA, 9 subtypes N1-N9) [1]. Highly pathogenic strains are primarily associated with H5 and H7 subtypes, although not all H5/H7 viruses are highly pathogenic [1, 2]. Pathogenicity is determined by the presence of multiple basic amino acids at the HA cleavage site, which allows systemic replication [1]. LPAI strains possess a monobasic cleavage site, restricting replication to respiratory and enteric epithelia [1]. The virus is further typed as type A, the only type known to cause significant disease in birds [2].

Epidemiology

AIV circulates endemically in wild waterfowl and shorebirds, which serve as natural reservoirs [1, 2]. Spillover into poultry occurs via direct or indirect contact with infected wild birds, contaminated fomites, feed, or water [1, 3]. Transmission can be rapid within flocks due to high stocking densities and shared equipment [2]. Once introduced, LPAI may mutate to HPAI following circulation in domestic gallinaceous poultry, particularly in H5 and H7 lineages [1]. Epidemiological patterns include seasonal peaks associated with wild bird migration and live bird market networks [3]. The Avian Influenza A Virus in Wild Birds and Poultry: Etiology, Epidemiology, Clinical Signs, Pathology, Diagnostics, Treatment, and Control article provides additional ecological context.

Clinical Signs

Clinical presentation depends on viral pathogenicity, host species, age, immune status, and concurrent infections [1, 2]. LPAI infections often cause mild or subclinical disease, with signs limited to respiratory distress, decreased feed intake, reduced egg production, and mild diarrhea [1, 2]. In contrast, HPAI is characterized by sudden onset and high morbidity and mortality (up to 100 percent) [1]. Clinical signs of HPAI include severe depression, cyanotic comb and wattles, edematous swelling of the head and periorbital tissues, petechial hemorrhages on the shanks, profuse watery diarrhea, respiratory distress, and neurological signs such as torticollis, incoordination, and paralysis [1, 2]. In breeding flocks, sharp drops in egg production and increased numbers of soft-shelled eggs are observed [1]. Turkeys and chickens are highly susceptible, whereas ducks and geese may carry HPAI without overt illness [1]. A more detailed account of avian influenza in chickens is available in a separate article.

Pathology

Gross lesions in HPAI cases include severe tracheitis, airsacculitis, multifocal necrotic foci in the pancreas, spleen, kidney, and liver, as well as hemorrhages on the heart and serosal surfaces [1, 2]. Gastrointestinal lymphoid tissues (e.g., cecal tonsils) may show necrosis and hemorrhage [1]. Microscopically, HPAI causes widespread necrosis of parenchymal cells and endothelial damage leading to edema and hemorrhage [1]. The presence of viral antigen in multiple organs confirms systemic infection [1]. LPAI lesions are typically confined to the respiratory and gastrointestinal tracts, with mild catarrhal to mucopurulent sinusitis, tracheitis, and enteritis [1]. For comparative pathology with other avian diseases, refer to the Infectious Coryza in Poultry article.

Diagnostics

Laboratory confirmation is essential for AIV detection and subtype identification [1, 4]. Sample types include oropharyngeal and cloacal swabs, feces, fresh tissues (trachea, lung, spleen, kidney), and serum [4]. Virus isolation in embryonated chicken eggs (specific pathogen free) remains the gold standard for recovery of live virus [1, 4]. Hemagglutination inhibition (HI) and neuraminidase inhibition (NI) tests determine HA and NA subtypes [4]. Molecular diagnostics include conventional reverse transcription polymerase chain reaction (RT-PCR) targeting the matrix gene and real-time RT-PCR (RRT-PCR) for rapid detection [1, 4]. For HPAI confirmation, sequencing or RT-PCR of the HA cleavage site is performed [4]. Serological surveys use agar gel immunodiffusion (AGID) or enzyme-linked immunosorbent assays (ELISA) to detect anti-influenza A antibodies [4]. Polymerase Chain Reaction (PCR) for Avian Influenza Virus Detection offers a detailed technical overview. Point-of-care devices, including lateral flow assays, are useful for field screening but require confirmatory testing [1]. CRISPR-Based Diagnostics for Avian Influenza represent an emerging molecular platform.

Surveillance

Surveillance is the cornerstone of avian influenza control and is mandated by the World Organisation for Animal Health (WOAH) for notifiable avian influenza [3]. Two primary surveillance types exist: passive surveillance (reporting of clinical suspicion or increased mortality) and active surveillance (systematic sampling of healthy flocks) [1, 3]. Active surveillance includes virological monitoring via RRT-PCR of environmental samples (e.g., boot swabs, dust) and serological monitoring of sentinel birds [3]. For high-risk premises such as live bird markets and layer flocks, risk-based intensified sampling is recommended [1]. Data integration using geographic information systems (GIS) and phylogenetic analysis supports early warning and tracing of outbreak strains [1]. The Highly Pathogenic Avian Influenza (HPAI) H5N1 in Poultry: Clinical Signs and Molecular Surveillance article provides further subtype-specific protocols. Surveillance results guide vaccination strategies, movement restrictions, and culling decisions [3]. A generalized surveillance workflow is depicted below.

flowchart TD
    A[Flocks and environment], > B[Sample collection: swabs, tissues, dust, serum]
    B, > C{Testing type}
    C, > D[Virological: RRT-PCR / virus isolation]
    C, > E[Serological: AGID / ELISA / HI]
    D, > F[Subtype determination: HA/NA typing]
    E, > G[Antibody detection]
    F, > H[Pathotyping: HA cleavage site sequencing]
    H, > I{Pathotype}
    I, > J[HPAI: report to WOAH]
    I, > K[LPAI: monitor and control]
    J, > L[Stamping out / biosecurity measures]
    K, > M[Risk assessment and continued surveillance]
    G, > N[Seroprevalence analysis]
    N, > O[Risk mapping and policy feedback]

Control

Control of AIV in poultry relies on a combination of biosecurity, surveillance, stamping out, and vaccination [1, 3]. Strict biosecurity includes preventing contact with wild birds, controlling movement of personnel and equipment, and disinfecting fomites [1]. For HPAI outbreaks, immediate depopulation of infected and contact flocks, quarantine, and thorough cleaning and disinfection are standard [3]. Vaccination, where permitted, employs inactivated whole virus or recombinant vectored vaccines (e.g., H5-expressing turkey herpesvirus) [1, 2]. However, vaccination can interfere with serological surveillance unless DIVA (Differentiating Infected from Vaccinated Animals) strategies are used [1]. WOAH guidelines require that vaccinated flocks remain under heightened surveillance [3]. A dedicated article on Avian Influenza Vaccine: Types, Strategies, and Efficacy in Poultry offers more detail.

Conclusion

Avian influenza A virus remains a major threat to poultry health, food security, and international trade. Clinical signs, while variable, provide early indicators of infection, particularly in highly pathogenic forms. Robust surveillance integrating molecular, serological, and epidemiological methods is essential for timely detection and response. Continued investment in diagnostic infrastructure, biosecurity, and research into viral evolution is warranted to mitigate future outbreaks.

References

[1] Swayne, D.E., Boulianne, M., Logue, C.M., McDougald, L.R., Nair, V., Suarez, D.L., et al. Diseases of Poultry. 14th ed. Wiley-Blackwell.

[2] Merck Veterinary Manual. 11th ed. Merck & Co., Inc.

[3] World Organisation for Animal Health (WOAH). Terrestrial Animal Health Code. Chapter 10.4: Infection with avian influenza viruses.

[4] World Organisation for Animal Health (WOAH). Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. Chapter 3.3.4: Avian influenza (infection with avian influenza viruses). *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.